financetom
Business
financetom
/
Business
/
American Express Global Business Travel Clear to Acquire CWT as US DOJ Drops Complaint
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
American Express Global Business Travel Clear to Acquire CWT as US DOJ Drops Complaint
Jul 29, 2025 1:08 PM

03:59 PM EDT, 07/29/2025 (MT Newswires) -- Global Business Travel Group's ( GBTG ) American Express Global Business Travel said Tuesday that the US Department of Justice has dropped its complaint challenging the travel company's takeover of peer CWT.

The transaction, valued at $540 million in cash and stock, is now expected to close in Q3, resulting in CWT shareholders owning about a 10% stake in the combined company, Amex GBT said.

The company said it sees the transaction to be "highly" accretive, with net synergies of $155 million.

The deal was first announced in March 2024 and received the UK competition regulator's clearance earlier this year.

Price: 6.67, Change: -0.04, Percent Change: -0.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ionis Pharmaceuticals Insider Sold Shares Worth $12,294,703, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $12,294,703, According to a Recent SEC Filing
Sep 5, 2025
03:21 AM EDT, 09/05/2025 (MT Newswires) -- Brett P Monia, Director, Chief Executive Officer, on September 03, 2025, sold 203,814 shares in Ionis Pharmaceuticals ( IONS ) for $12,294,703. Following the Form 4 filing with the SEC, Monia has control over a total of 180,009 common shares of the company, with 180,009 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874015/000087401525000221/xslF345X05/edgardoc.xml ...
Ionis Pharmaceuticals Insider Sold Shares Worth $1,195,421, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $1,195,421, According to a Recent SEC Filing
Sep 5, 2025
03:26 AM EDT, 09/05/2025 (MT Newswires) -- Eugene Schneider, Executive Vice President, Chief Clinical Development Officer, on September 03, 2025, sold 19,658 shares in Ionis Pharmaceuticals ( IONS ) for $1,195,421. Following the Form 4 filing with the SEC, Schneider has control over a total of 51,507 common shares of the company, with 51,507 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874015/000087401525000211/xslF345X05/edgardoc.xml...
Palantir Technologies Insider Sold Shares Worth $12,511,782, According to a Recent SEC Filing
Palantir Technologies Insider Sold Shares Worth $12,511,782, According to a Recent SEC Filing
Sep 5, 2025
03:31 AM EDT, 09/05/2025 (MT Newswires) -- David A. Glazer, Chief Financial Officer and Treasurer, on September 02, 2025, sold 81,000 shares in Palantir Technologies ( PLTR ) for $12,511,782. Following the Form 4 filing with the SEC, Glazer has control over a total of 431,169 Class A common shares of the company, with 431,169 shares held directly. SEC Filing:...
Ionis Pharmaceuticals Insider Sold Shares Worth $1,018,298, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $1,018,298, According to a Recent SEC Filing
Sep 5, 2025
03:22 AM EDT, 09/05/2025 (MT Newswires) -- B Lynne Parshall, Director, on September 02, 2025, sold 20,000 shares in Ionis Pharmaceuticals ( IONS ) for $1,018,298. Following the Form 4 filing with the SEC, Parshall has control over a total of 66,344 common shares of the company, with 66,344 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874015/000087401525000222/xslF345X05/edgardoc.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved